Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients

Completed · Not applicable

Conditions studied: Glaucoma

In brief

Glaucoma is a leading cause of blindness worldwide. Non-adherence to glaucoma medication, which may result in loss of vision, is known to be prevalent. Available information regarding adherence to prescribed medical therapy suggests that some apparent treatment failures may actually be due to non-adherence. The investigators' specific aim is to conduct a study that will examine the effect of a glaucoma educator intervention on adherence to topical glaucoma therapy. The investigators' hypothesis is that patient education and counseling delivered by a trained glaucoma educator, through both planned visits and telephone contacts, will increase adherence to topical glaucoma therapy.

Key facts

Study ID

NCT00454922

Run by

University of Colorado, Denver

People needed

44

Starts

2007-10-01

Expected to finish

2012-01-01

Last updated by the study team

2012-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of primary or secondary open angle glaucoma.
• Currently on monotherapy drop treatment for glaucoma.
• Age > 18 years.
• Patient has presented for care at the Rocky Mountain Lions Eye Institute Glaucoma Center.

You may not qualify if…

• Inability to independently administer eye drops due to physical disability as reported by the patient.
• Cognitive impairment that would interfere with the ability to self-administer medications as evidenced by a TICS score < 16.
• Patients who demonstrate > 80% adherence to glaucoma treatment during the 30 day run-in period.
• It is anticipated that the patient will require glaucoma surgery within the next six months.

Where it is running

• Rocky Mountain Lions Eye Institute — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.